MGNXHealthcareMicro-Cap

MACROGENICS INC Insider Trading Activity

Every SEC Form 4 insider transaction reported for MACROGENICS INC (MGNX), sourced directly from SEC EDGAR and updated as new filings are accepted.

Last updated:

Quick Answer

Are MGNX insiders buying or selling?

MACROGENICS INC insiders reported 16 open-market buys ($38.9M) and 39 sells ($10.2M) across 55 Form 4 filings — a net buying position of $28.7M.

Source: SEC EDGAR Form 4

Key Statistics (as of Aug 21, 2025)

Total Form 4 filings
55
SEC EDGAR
Insider filers
11
Insider buys (16)
$38.9M
Insider sells (39)
$10.2M

Insider sentiment

Net buying

Net insider flow of $28.7M in net buying.

Recent MGNX insider transactions

DateInsiderRoleTypeSharesPriceValue
Aug 21, 2025William K HeidenDirectorPurchase100.0K$1.51$150.5K
Feb 19, 2025Beth Ann SmithVP, Controller & TreasurerSale423$2.56$1.1K
Apr 8, 2024Jeffrey Stuart PetersSenior VP and General CounselSale51.4K$15.55$799.1K
Mar 8, 2024Jeffrey Stuart PetersSenior VP and General CounselSale19.6K$21.50$421.9K
Mar 6, 2024Eric Blasius RisserChief Operating OfficerSale41.2K$19.76$813.5K
Mar 6, 2024Thomas SpitznagelSr VP, Technical OpsSale10.0K$20.00$200.0K
Mar 6, 2024James KarrelsSVP, CFO and SecretarySale30.0K$20.50$615.0K
Feb 28, 2024Jeffrey Stuart PetersSenior VP and General CounselSale16.1K$17.22$277.7K
Feb 7, 2024Ezio BonviniSr VP, Research & CSOSale3.3K$18.00$60.0K
Feb 7, 2024Jeffrey Stuart PetersSenior VP and General CounselSale76.3K$16.50$1.3M
Feb 2, 2024Ezio BonviniSr VP, Research & CSOSale13.3K$15.00$199.7K
Jan 22, 2024Ezio BonviniSr VP, Research & CSOSale13.3K$12.00$159.8K
Dec 21, 2023Ezio BonviniSr VP, Research & CSOSale18.9K$10.08$190.3K
Oct 4, 2023V N Biotech Target10% OwnerPurchase150.0K$4.46$669.6K
Sep 11, 2023V N Biotech Target10% OwnerPurchase200.0K$5.26$1.1M
Sep 1, 2023Edward HurwitzDirectorPurchase15.0K$4.91$73.7K
Mar 14, 2023Jeffrey Stuart PetersSenior VP and General CounselSale5.4K$6.03$32.4K
Feb 16, 2023V N Biotech Target10% OwnerPurchase500.0K$5.07$2.5M
Jan 23, 2023V N Biotech Target10% OwnerPurchase150.0K$5.30$794.9K
Dec 28, 2022V N Biotech Target10% OwnerPurchase400.0K$5.75$2.3M
Nov 25, 2022V N Biotech Target10% OwnerPurchase300.0K$5.96$1.8M
Oct 25, 2022V N Biotech Target10% OwnerPurchase500.0K$4.50$2.2M
Oct 21, 2022V N Biotech Target10% OwnerPurchase454.4K$3.89$1.8M
Jun 17, 2022James KarrelsSVP, CFO and SecretaryPurchase40.0K$2.47$98.8K
Nov 23, 2021V N Biotech Target10% OwnerPurchase200.0K$18.50$3.7M

Showing the 25 most recent of 55 Form 4 filings for MACROGENICS INC.

Most active MGNX insiders

  • Eric Blasius Risser14 filings
  • V N Biotech Target13 filings
  • Jeffrey Stuart Peters8 filings
  • Ezio Bonvini6 filings
  • Thomas Spitznagel6 filings

Ask anything about MGNX insider activity

Use Trabud's AI agent to query MACROGENICS INC's Form 4 history in plain English — "Show me MGNX CEO purchases this year" or compare it against any other ticker.

Open the AI agent

MGNX insider trading FAQ

Are MACROGENICS INC insiders buying or selling?

Across 55 SEC Form 4 filings, MACROGENICS INC (MGNX) insiders reported 16 open-market purchases totaling $38.9M and 39 sales totaling $10.2M. That is a net buying position of $28.7M.

How many insiders trade MGNX stock?

11 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for MACROGENICS INC. The most recent filing was accepted on Aug 21, 2025.

Where does Trabud get MGNX insider trading data?

All MGNX insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.

Looking for another company? Browse all tracked companies.

Related Content